Table 3 |
|||
|
Odds ratios and 95% confidence intervals (CI) for age as predictor of sustained virological response after treatment with peginterferon and ribavirin in 418 chronically HCV infected patients, divided by genotype (133 genotype 1, 285 genotype 2/3) |
|||
|
Genotype 1 |
Genotype 2/3 |
||
|
|
|||
|
Odds ratio (95% CI)* |
Odds ratio (95% CI)* |
||
|
|
|||
|
Age |
≤ 45 years |
1 |
1 |
|
|
|||
|
> 45 years |
0.23 (0.09-0.63) |
0.58 (0.33-1.00) |
|
|
|
|||
|
|
|||
|
*adjusted for gender, nationality, route of infection, HCV-RNA, ALT, treating department (gastroenterology/hepatology vs. infectious diseases), treatment completion as scheduled, ended before scheduled or dose reduction |
|||
|
Hansen et al. BMC Infectious Diseases 2011 11:177 doi:10.1186/1471-2334-11-177 |
|||
